EGFR-mutant Non-small Cell Lung Cancer Recruiting Phase 1 Trials for Ribociclib (DB11730)

IndicationStatusPhase
DBCOND0092543 (EGFR-mutant Non-small Cell Lung Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03333343Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCTreatment